Where does Spatial Transcriptomics AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Spatial Transcriptomics AB ranks #33,395 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Spatial Transcriptomics AB hold?

Spatial Transcriptomics AB holds 8 US utility patents granted between 2018 and 2023, spanning 6 technology areas.

What is Spatial Transcriptomics AB's Innovation Score?

Spatial Transcriptomics AB has an Innovation Score of 51.3 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Spatial Transcriptomics AB's patent grant rate increasing or decreasing?

Spatial Transcriptomics AB's recent grant velocity is +600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Spatial Transcriptomics AB's patents?

Spatial Transcriptomics AB's patents average 26.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Spatial Transcriptomics AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Spatial Transcriptomics AB

Q: What technology areas does Spatial Transcriptomics AB focus on?

Spatial Transcriptomics AB's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 8 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Spatial ranks #33,395 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 6 technology areas.

#33,395
of 49,997 US assignees by volume: Top 12%
by Innovation Score (51.3/100): 26.6
avg claims per patent: +600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33395 · Foreign Corporation #33,395 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,395/49,997
PHOTO-FINISH Sonoma Pharmaceuticals
CPC-NARROW C12N · 6 areas
INNOV-PAR 51.3/100
CLAIMS-DENSE 26.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sonoma Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Smartsens TECHNOLOGY… · near

51
Actym Therapeutics · near

51
Spatial Transcriptom… · this assignee

51
Veir · near

51
Water Harvesting · near

51
3D Lighting… · lowest

7

What this shows Spatial's Innovation Score is 51.3/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Spatial's grants concentrate

Spatial Transcriptomics AB is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2018. By volume, Spatial sits between Sonoma Pharmaceuticals, Inc. and Spherical Block LLC.

Spatial's three-year grant acceleration

Spatial Transcriptomics AB shows 6 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sonoma Pharmaceut…

8
Sophono

8
Southchip Semicon…

8
Southwest Forestr…

8
Specialty Sales

8
Spectrum Health I…

8
Speedplay

8
Spherical Block

8
Spatial Transcrip… ◀

8

What this shows Spatial holds 8 patents at rank #33,433, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Spatial

By rank, the assignees closest to #33,433 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Spatial's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Spatial, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Veir, Inc. 51 Actym Therapeutics, Inc. 51 Water Harvesting, Inc. 51 Smartsens TECHNOLOGY(HK) Co., Limited 51

Spatial's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Spatial Transcriptomics AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	12.5%
2021	1	12.5%
2022	4	50.0%
2023	2	25.0%

Which technologies does Spatial Transcriptomics AB patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 5

C12Y - Enzymes 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#33,395

of 49,997 tracked assignees

Innovation Score

51.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Spatial Transcriptomics AB's patent record in context - here's where to go next.

Spatial Transcriptomics AB's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #33,395 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Spatial Transcriptomics AB against Sonoma Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.